Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Doi

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Acta Medica Okayama|November 16, 2005
A new HLA-DRB1 genotyping method using single nucleotide polymorphism (SNP) analysis with multiplex primer extension reactions and its application to mixed samplesKiyomi Imabayashi, Yuji Yamamoto, Sachiyo Inagaki, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 5, 2012
Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatinAmr S Abu Lila, Haruna Matsumoto, Yusuke Doi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2011
A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNAKazuya Nakamura, Amr S Abu Lila, Mariko Matsunaga, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 24, 2013
Sequential treatment of oxaliplatin-containing PEGylated liposome together with S-1 improves intratumor distribution of subsequent doses of oxaliplatin-containing PEGylated liposomeHiroyuki Nakamura, Yusuke Doi, Amr S Abu Lila, et al.
Chemical & Pharmaceutical Bulletin|May 1, 2022
The Challenge to Deliver Oxaliplatin (l-OHP) to Solid Tumors: Development of Liposomal l-OHP FormulationsNana Cristina Amorim Matsuo, Hidenori Ando, Yusuke Doi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2009
Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor modelAmr S Abu Lila, Shinji Kizuki, Yusuke Doi, et al.
International Journal of Pharmaceutics|February 8, 2012
Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?Amr S Abu Lila, Tomoko Okada, Yusuke Doi, et al.
Biochemical and Biophysical Research Communications|April 25, 2006
The decapping enzyme Dcp1 participates in translation termination through its interaction with the release factor eRF3 in budding yeastSatoshi Kofuji, Takeshi Sakuno, Shinya Takahashi, et al.
Nucleic Acids Research|March 21, 2006
Synthesis and characterization of oligonucleotides containing 2'-fluorinated thymidine glycol as inhibitors of the endonuclease III reactionYusuke Doi, Atsushi Katafuchi, Yoshie Fujiwara, et al.
Legal Medicine (Tokyo, Japan)|August 26, 2003
Typing of Y chromosome single nucleotide polymorphisms in a Japanese population by a multiplexed single nucleotide primer extension reactionSachiyo Inagaki, Yuji Yamamoto, Yusuke Doi, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Acta Medica Okayama|November 16, 2005
A new HLA-DRB1 genotyping method using single nucleotide polymorphism (SNP) analysis with multiplex primer extension reactions and its application to mixed samplesKiyomi Imabayashi, Yuji Yamamoto, Sachiyo Inagaki, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 5, 2012
Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatinAmr S Abu Lila, Haruna Matsumoto, Yusuke Doi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2011
A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNAKazuya Nakamura, Amr S Abu Lila, Mariko Matsunaga, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 24, 2013
Sequential treatment of oxaliplatin-containing PEGylated liposome together with S-1 improves intratumor distribution of subsequent doses of oxaliplatin-containing PEGylated liposomeHiroyuki Nakamura, Yusuke Doi, Amr S Abu Lila, et al.
Chemical & Pharmaceutical Bulletin|May 1, 2022
The Challenge to Deliver Oxaliplatin (l-OHP) to Solid Tumors: Development of Liposomal l-OHP FormulationsNana Cristina Amorim Matsuo, Hidenori Ando, Yusuke Doi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2009
Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor modelAmr S Abu Lila, Shinji Kizuki, Yusuke Doi, et al.
International Journal of Pharmaceutics|February 8, 2012
Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?Amr S Abu Lila, Tomoko Okada, Yusuke Doi, et al.
Biochemical and Biophysical Research Communications|April 25, 2006
The decapping enzyme Dcp1 participates in translation termination through its interaction with the release factor eRF3 in budding yeastSatoshi Kofuji, Takeshi Sakuno, Shinya Takahashi, et al.
Nucleic Acids Research|March 21, 2006
Synthesis and characterization of oligonucleotides containing 2'-fluorinated thymidine glycol as inhibitors of the endonuclease III reactionYusuke Doi, Atsushi Katafuchi, Yoshie Fujiwara, et al.
Legal Medicine (Tokyo, Japan)|August 26, 2003
Typing of Y chromosome single nucleotide polymorphisms in a Japanese population by a multiplexed single nucleotide primer extension reactionSachiyo Inagaki, Yuji Yamamoto, Yusuke Doi, et al.
Pageof 4